Innovations in viral vector development, scale up and production
Watch this educational webinar and learn how recent innovation can help you to significantly push the boundaries of viral vectors productivity and quality. Discover how recent innovation in areas such as cells, media and transfection agents can boost and standardise your process, as illustrated by our lentiviral case study.
Activation and Expansion of Tregs for use in Cell Therapy
Our studies demonstrate that our new CTS Dynabeads Treg Xpander results in superior regulatory T cell (Treg) expansion with maintenance of high %FOXP3 expression after 12-14 days.
Nunc Cell Factory equipment
Scaling up adherent cell culture can be a difficult process for many vaccine, cell therapy, gene therapy, and viral vector manufacturers. Some cells can alter their properties if they are not cultured in specific conditions.
Optimization of a Phenol Red-Free T Cell Expansion Medium
Adoptive immunotherapy displays immense potential as an immunotherapeutic strategy for patients with advanced malignancies. Phenol red has been a mainstay in media used for the ex vivo expansion of primary T cells.